Along this line of argumentation, our investigation focuses on the role of nuclear orphan receptor NR2F6, an established immune checkpoint of the CD8+ T cell effector compartment, as a candidate driver of cerebral malaria pathology. The gene discussed is NR2F6; the disease is cerebral malaria.